The Journey from Point A to Point B: How to get from Clinical Inquiry to Conducting Nursing Research
JoAnn Mick, PhD, RN, NEA-BC, Nurse Researcher, Memorial Hermann - Texas Medical Center

This presentation will define three types of clinical inquiry: evidence based practice (EBP), quality improvement (QI), and research. Steps nurses can take to move from having a practice idea or question to making a decision about conducting nursing research will be described. Information provided will include how to identify a problem/topic, how to view a problem/topic from a variety of practice angles, key sources of evidence to consider when conducting a literature review, making a decision to conduct research, and steps of the research process. The role of nurses in EBP, quality improvement, and research will be described in terms of how nurses can contribute to the body of knowledge that guides nursing practice.

Continuing Education Credit Hours: SOCRA designates this educational activity for a maximum of 1 Continuing Education Credits for SOCRA CE and Nurse CNE. SOCRA designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)^(TM). Physicians should claim credit commensurate with the extent of their participation in the activity. c

Accreditation Statements:
CME for Physicians: The Society of Clinical Research Associates is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CNE for Nurses: Society of Clinical Research Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

DISCLOSURE OF RELATIONSHIPS AND DECLARATIONS: CNE AND CME ACCREDITED SOCRA PROGRAMS

SOCRA adheres to the ACCME’s & ANCC’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

SOCRA program content addresses regulatory issues and clinical research policies and procedures, no commercial therapies are discussed, no commercial (drug/device/biologic) products are discussed, and no commercial support is involved with SOCRA programs.

Planners and Speakers for programs have no undisclosed commercial relationships.